http://www.acc.org/clinical/guidelines/nov96/1999/jac1716pIIa.htm

1999 UPDATED GUIDELINE
(WEB VERSION)

ACC/AHA Guidelines for the Management of Patients With Acute
Myocardial Infarction 

II. Prehospital Issues
Recommendations 

Class I 


1. Availability of 911 access. 
2. Availability of an emergency medical services (EMS) system staffed
by persons trained to treat cardiac arrest with defibrillation if
indicated and to triage patients with ischemic-type chest discomfort.


Class IIa

1. Availability of a first-responder defibrillation program in a
tiered response system. 
2. Healthcare providers educate patients/families about signs and
symptoms of acute MI, accessing EMS, and medications. 
Class IIb 


1. Twelve-lead telemetry. 
2. Prehospital thrombolysis in special circumstances (eg, transport
time greater than 90 minutes). 

Each year approximately 800 000 persons in the United States
experience acute MI, and about 213,000 of them die. At least one half
of these persons die within 1 hour of onset of symptoms and before
reaching a hospital emergency department.3,4 It has been recognized
for more than 3 decades that the majority of these sudden cardiac
deaths are the result of fatal arrhythmias that often can be stopped
by emergency cardiopulmonary resuscitation (CPR), defibrillation, and
prompt ACLS. More recent data regarding the time-dependent benefits
of thrombolytic therapy provide added stimulus to develop more
effective means of expediting delivery of medical care to persons
with acute MI. It has been shown that early treatment results in
reductions in mortality, infarct size, and improved LV function.5-7
Clearly, delay in treating patients with suspected acute MI is a
critical factor in decreasing the overall survival rate. For these
reasons the National Heart, Lung, and Blood Institute (NHLBI) has
initiated the National Heart Attack Alert Program (NHAAP), a
coordinated national program that extends the ACC/AHA recommendations
promoting rapid identification and treatment of patients with acute
MI.8,9 
Recognition and Management 

It has been demonstrated that most patients do not seek medical care
for 2 hours or more after symptom onset. A sizable proportion wait 12
hours or more. In general, reperfusion therapy beyond 12 hours may
offer little benefit.8,9 The components of delay from symptom onset
to treatment are (1) patient related (ie, failure to recognize the
seriousness of the problem and delay in seeking emergency care); (2)
prehospital evaluation, treatment, and transport times; and (3) time
required for diagnosis and initiation of treatment in the hospital.
In most cases, patient-related delay is the longest, but each
component moves the patient further away from the golden first hour
to a time when the effect of treatment is lessened. Effective early
intervention cannot occur without appropriate patient and family
action early after symptom onset. 

Intervention Strategies 

Interventions to minimize patient delay are primarily educational in
nature and focus on what to do when ischemic-type chest discomfort
occurs. Patients with known heart disease or those at high risk of
acute MI should be educated by physicians, nurses, and staff about
common symptoms of acute MI and appropriate actions to take after
symptom onset. Patients should be given an action plan that covers
(1) prompt use of aspirin and nitroglycerin if available, (2) how to
access EMS, and (3) location of the nearest hospital that offers
24-hour emergency cardiac care. Ideally patients should be given a
copy of their resting ECG as a baseline to aid physicians in the
emergency department. Because chest discomfort is the most common
symptom of infarction,10 patients need simple instructions to respond
effectively. In addition to being made aware that chest discomfort
may be more of a pressure sensation than actual pain, they should
understand that the discomfort can be referred to the arm, throat,
and lower jaw and can be accompanied by breathing difficulty,
diaphoresis, or a feeling of impending doom.11,12 Reviewing the
description of possible symptoms and the action plan in simple,
understandable terms at each visit is extremely important, because
studies have indicated that many patients minimize the importance of
their symptoms or deny the possibility of acute MI.12,13 Discussions
with patients should emphasize the importance of acting promptly.
Family members should be included in these discussions and enlisted
as advocates for action when symptoms of infarction are apparent.8,11


The role of medications to be taken at onset of symptoms must be
tailored to each individual. Current advice is to take 1
nitroglycerin tablet sublingually at the onset of ischemic-type chest
discomfort and another every 5 minutes for a total of 3 doses. If
symptoms persist, the patient should call 911 emergency services or
obtain other emergency transportation to the hospital-not the
physician's office. The hospital should be staffed round-the-clock by
physicians and nurses competent in (1) performing an initial
evaluation, including an ECG, (2) providing cardiac monitoring and
ACLS, and (3) providing reperfusion therapy. Patients who can be
identified in the field as being at high risk with signs of shock,
pulmonary congestion, heart rate greater than 100 beats per minute
(bpm), and systolic blood pressure less than 100 mm Hg ideally should
be triaged to facilities capable of cardiac catheterization and
revascularization. Although it has not yet been demonstrated that
initial triage of such patients to tertiary centers results in
improved outcome compared with initial management in primary
facilities, this approach has the desirable effect of obviating the
need of emergency transfer of a critically ill patient from one
hospital to another, interrupting intensive nursing care and possibly
delaying diagnosis and treatment. 

Use of the EMS system almost always decreases delays in initiation of
definitive care.8 Accordingly, the physician should discuss the use
of 911 or other local emergency numbers with the patient and should
also be aware of the nature and capability of the care that will be
rendered. The physician should know whether or not the local EMS
system can provide defibrillation and other lifesaving care and
should also be familiar with the triage strategy for patients with
suspected MI. 

Emergency Medical Services Systems 

Each community prehospital EMS system should develop a plan to triage
and provide rapid initial medical care to patients with ischemic-type
chest discomfort. In most cities in the United States trained
emergency medical technicians (EMTs) work in several different
healthcare settings: (1) the emergency medical section of the fire
department, (2) hospital-based ambulance systems, and (3) department
of health services. To minimize time to treatment, particularly for
cardiopulmonary arrest, many systems incorporate professional first
responders to provide CPR and defibrillation. Ideally there should be
a sufficient number of trained personnel so that a first responder
can be at the victim's side within 5 minutes. Public service
personnel such as police, firefighters, public works employees, and
other first-aid providers have frequently been trained successfully
as first responders. A sense of urgency in managing patients with
ischemic-type chest discomfort must be imparted to EMS personnel.
Rapid identification and treatment of the acute MI patient is
imperative. 

Early access to EMS is promoted by a 911 system currently available
to 80% of the United States population.8,9 Enhanced 911 systems
provide the caller's location, permitting rapid dispatch of
prehospital personnel to locations even if the caller is not capable
of verbalizing or the dispatcher cannot understand the location of
the emergency. Unfortunately the capabilities of EMS systems vary
considerably among communities, some providing little beyond first
aid, whereas others have formal, advanced protocols for the
management of patients with suspected MI or ischemic-type chest
discomfort. The latter offers promise in favorably influencing
outcomes in such patients. Because patients with acute MI are at
relatively high risk of sudden death during the first hour after
onset of symptoms, a prehospital EMS system that can provide
defibrillation is mandatory.8,14 The survival of patients who develop
ischemia-induced ventricular fibrillation (VF) depends on rapid
deployment of defibrillation. The survival rate of prehospital
treatment for all patients with cardiac arrest (those with and
without acute MI) varies from 1% to 25%.15-19 If VF occurs under
observation and immediate defibrillation is successful, almost all
such patients survive and recover completely.20 Therefore, the AHA
has recommended that every ambulance that transports cardiac arrest
victims should be equipped with a defibrillator.21 However, this goal
is yet to be realized. 

Automated external defibrillators (AEDs) have been shown to be
effective and safe.18,19,21-23 They can be used by first responders
with a minimum of training to quickly and accurately analyze rhythms
and deliver defibrillation shocks to patients in VF. Systems that
incorporate AEDs to shorten response times are highly desirable.
Prehospital providers trained and capable of providing ACLS with
drugs, intubation, and other therapy further improve the patient's
chances for survival. 

Undirected prehospital assessments of patients with ischemic-type
chest discomfort can lead to excessive evaluation times and can
impede rapid delivery of appropriate therapy.24 Procedures need to be
in place for each EMS system so that a targeted history, physical
examination, prehospital ECG, and initial treatment take place in 20
minutes or less. Recently, highly skilled prehospital healthcare
providers have been trained and equipped to evaluate patients with
ischemic-type chest discomfort by using a checklist and performing
12-lead ECGs in the prehospital setting (Table 1). The checklist
should be designed to determine the likelihood of MI and the presence
or absence of comorbid conditions and underlying conditions in which
thrombolytic therapy may be hazardous. The checklist should
facilitate detection of patients with suspected MI who are at
especially high risk, including those with tachycardia (>=100 bpm),
hypotension (<=100mm Hg), or signs of shock or pulmonary edema. If
available, prehospital ECGs should be obtained in all patients with
ischemic-type chest discomfort and transmitted to the ED physician
for interpretation and instructions. Such advances accelerate the
initial diagnosis and administration of thrombolytic agents after the
patient's arrival in the ED.5,25,26 Active involvement of local
healthcare providers-particularly cardiologists and emergency
physicians-is needed to formulate local EMS protocols for patients
with suspected MI, provide training, and secure equipment. Virtually
all states have regulations and standards for emergency personnel,
training, and equipment. It is useful for those involved in the
emergency care of patients with acute MI to be familiar with these
regulations. 

Prehospital-Initiated Thrombolysis 

Randomized controlled trials of fibrinolytic therapy have
demonstrated the benefit of initiating thrombolytic therapy as early
as possible after onset of ischemic-type chest discomfort.27-29 It
seems rational therefore to expect that if thrombolytic therapy could
be started at the time of prehospital evaluation, a greater number of
lives could be saved. The value of reducing delay until treatment
depends not only on the amount of time saved but when it occurs.
Available data suggest that time saved within the first 1 to 2 hours
has greater biological importance than time saved during the later
stages of acute MI.5,7,27,28,30 Several randomized trials of
prehospital-initiated thrombolysis have advanced our understanding of
the impact of early treatment.5,31-34 Acquisition of ECGs in the
field and use of a chest-pain checklist (Table 1) leads to more rapid
prehospital and hospital care.5,26 Although none of the individual
trials showed a reduction in mortality with prehospital-initiated
thrombolytic therapy, a meta-analysis of all available trials
demonstrated a 17% relative improvement in outcome associated with
prehospital therapy (95% confidence interval [CI], 2% to 29%).34 The
greatest improvement in outcome is observed when treatment can be
initiated in the field 60 to 90 minutes earlier than in the
hospital.5,33-35 

Although prehospital-initiated thrombolytic therapy results in
earlier treatment, the time savings can be offset in most cases by an
improved hospital triage with resultant "door-to-needle time''
reduced to 30 minutes or less.4 However, only a small percentage (5%
to 10%) of patients with chest pain in the prehospital setting have
acute MI and are eligible for thrombolytic therapy.5,25,36 Ensuring
proper selection of patients for therapy can be difficult, and
avoiding therapy when it is contraindicated has important medical,
legal, and economic implications. For these reasons, a general
national policy of prehospital thrombolytic therapy cannot currently
be advocated. However, in special settings in which physicians are
present in the ambulance or prehospital transport times are 90
minutes or longer, this therapeutic strategy should be considered.
Observations from prehospital trials suggest that prehospital systems
should focus on early diagnosis (a relatively minor augmentation in
prehospital services) instead of delivery of therapy. 


� 1999 by the American College of Cardiology and 
American Heart Association, Inc. 




__________________________________________________
Do You Yahoo!?
Try FREE Yahoo! Mail - the world's greatest free email!
http://mail.yahoo.com/

Répondre à